Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 11, 2022
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BBMorten Aagaard Nielsen, Kristian Juul-Madsen, John Stegmayr, et al.
Rheumatology (Oxford, England)|June 23, 2016
A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritisMorten Aagaard Nielsen, Thomas Andersen, Anders Etzerodt, et al.
Plos One|February 6, 2016
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment ResponseTue Wenzel Kragstrup, Babak Jalilian, Kresten Krarup Keller, et al.
Arthritis Research & Therapy|March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progressionTue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
RMD Open|June 12, 2024
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international surveyPierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, et al.
Scandinavian Journal of Public Health|December 9, 2024
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatologyBente Glintborg, Mats Hansson, Hilde Berner Hammer, et al.
Annals of the Rheumatic Diseases|May 15, 2023
Points to consider: EULAR-UEMS standards for the training of European rheumatologistsAlessia Alunno, Tadej Avcin, Catherine Haines, et al.
Annals of the Rheumatic Diseases|December 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancerEden Sebbag, Kim Lauper, Juan Molina-Collada, et al.
Annals of the Rheumatic Diseases|December 31, 2024
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancerEden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancerEden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, et al.
Pageof 5